We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
ObsEva SA | NASDAQ:OBSV | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.1018 | 0.1017 | 0.106 | 0 | 00:00:00 |
As filed with the Securities and Exchange Commission on March 28, 2023
Registration No. 333-263234
Registration No. 333-249457
Registration No. 333-231629
Registration No. 333-216170
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
POST-EFFECTIVE AMENDMENT NO. 1 TO:
Form S-8 Registration No. 333-263234
Form S-8 Registration No. 333-249457
Form S-8 Registration No. 333-231629
Form S-8 Registration No. 333-216170
UNDER
THE SECURITIES ACT OF 1933
OBSEVA SA
(Exact name of Registrant as specified in its charter)
Switzerland | N/A | |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
Chemin des Aulx, 12
1228 Plan-les-Ouates
Geneva, Switzerland
Tel: +41 22 552 38 40
(Address and telephone number, including area code of Registrants principal executive offices)
Cogency Global Inc.
122 East 42nd Street, 18th Floor
New York, New York 10168
Tel: (212) 947-7200
(Name, address, including zip code, and telephone number, of agent for service)
Copies to:
Divakar Gupta
Ryan Sansom
Cooley LLP
55 Hudson Yards
New York, New York 10001
Tel: (212) 479-6000
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of large accelerated filer, accelerated filer, smaller reporting company, and emerging growth company in Rule 12b-2 of the Exchange Act.
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
Non-accelerated filer | ☒ | Smaller reporting company | ☒ | |||
Emerging growth company | ☐ |
DEREGISTRATION OF SECURITIES
This Post-Effective Amendment No. 1 (this Post-Effective Amendment) relates to the following Registration Statements on Form S-8 (each a Registration Statement, and collectively, the Registration Statements), filed with the Securities and Exchange Commission (the SEC) by ObsEva SA (the Registrant):
| Registration Statement No. 333-263234, filed with the SEC on March 2, 2022, pertaining to the registration of 4,753,671 common shares of the Registrant reserved for future issuance under the 2017 Equity Incentive Plan, as amended (the Plan); |
| Registration Statement No. 333-249457, filed with the SEC on October 13, 2020, pertaining to the registration of 3,204,124 common shares of the Registrant reserved for future issuance under the Plan; |
| Registration Statement No. 333-231629, filed with the SEC on May 21, 2019, pertaining to the registration of 1,749,995 common shares of the Registrant reserved for future issuance under the Plan; and |
| Registration Statement No. 333-216170, filed with the SEC on February 22, 2017, pertaining to the registration of 4,172,623 common shares of the Registrant reserved for future issuance under the Plan. |
The Registrant is filing this Post-Effective Amendment to deregister any and all securities that remain unsold under the Registration Statements as of the date hereof. In accordance with the undertakings made by the Registrant in the Registration Statements to remove from registration by means of a post-effective amendment any securities that had been registered for issuance but remain unsold at the termination of the offering, the Registrant hereby removes and withdraws from registration any and all securities registered pursuant to the Registration Statements that remain unsold as of the date hereof. Note that the numbers of securities listed above do not take into account any applicable corporate actions, such as stock splits, that may have been taken in the interim.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Post-Effective Amendment No. 1 to the Registration Statements on Form S-8 to be signed on its behalf by the undersigned, thereunto duly authorized, in Geneva, Switzerland, on March 28, 2023.
OBSEVA SA | ||
By: | /s/ Will Brown | |
Will Brown, Interim Chief Executive Officer and Chief Financial Officer |
SIGNATURE OF AUTHORIZED U.S. REPRESENTATIVE
Pursuant to the Securities Act of 1933, as amended, the undersigned, the duly authorized representative in the United States of ObsEva SA, has signed this Post-Effective Amendment No. 1 to Registration Statements on Form S-8 on March 28, 2023.
Authorized U.S. Representative Cogency Global Inc. | ||
By: | /s/ Colleen A. DeVries | |
Name: Colleen A. DeVries | ||
Title: Senior Vice-President on behalf of Cogency Global Inc. |
1 Year ObsEva Chart |
1 Month ObsEva Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions